XML 10 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 422 $ 142
Cost of sales (11) (54)
Gross profit 411 88
Research and development costs (9,122) (20,813)
General and administrative expenses (7,026) (7,684)
Operating loss (15,737) (28,409)
Foreign currency gain/(loss), net (482) (3,769)
Other income, net 571 969
Benefit from R&D credit 691 2,679
Loss before income tax expense (14,957) (28,530)
Income tax expense 0 0
Net Loss $ (14,957) $ (28,530)
Loss per share basic $ (0.11) $ (0.2)
Loss per share diluted $ (0.11) $ (0.2)
Weighted-average shares outstanding basic 141,702,578 141,678,734
Weighted-average shares outstanding diluted 141,702,578 141,678,734